Reuters logo
BRIEF-Ewopharma announces commercial partnership with Eisai
June 22, 2017 / 3:11 PM / 3 months ago

BRIEF-Ewopharma announces commercial partnership with Eisai

June 22 (Reuters) - Ewopharma AG

* Ewopharma announces commercial partnership with Eisai Co

* Ewopharma says it will commercialise Halaven (eribulin mesylate) in nine countries within European Union and in two countries outside of EU

* Ewopharma will also commercialise Targretin in Hungary and Poland as well as Zonegran in Hungary

* Ewopharma says had acquired rights to commercialise several of Eisai’s products in eleven countries in central and eastern Europe Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below